CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer

@inproceedings{Sun2016CPA4IA,
  title={CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer},
  author={Lichao Sun and Yipeng Wang and Hebao Yuan and Joseph P. Burnett and Jian Pan and Zhihua Yang and Yuliang Ran and Ila Myers and Duxin Sun},
  booktitle={Journal of Cancer},
  year={2016}
}
Background. Carboxypeptidase A4 (CPA4) belongs to a member of the metallocarboxypeptidase family, and its expression in lung cancer samples and clinical significance are still not investigated until now. In this study, we aimed to evaluate the level of CPA4 in non-small-cell lung cancer (NSCLC) samples and correlate its level with clinical outcome. Methods. CPA4 gene expression in lung cancer tissues were analyzed by using the Oncomine database (www.oncomine.org). The expression of CPA4… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer

  • International journal of medical sciences
  • 2019
VIEW 2 EXCERPTS
CITES METHODS & BACKGROUND

Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.

  • Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
  • 2017

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2008
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Diagnostic value of CEA and CYFRA 21 - 1 tumor markers in primary

K Matsuoka, S Sumitomo, N Nakashima, D Nakajima, N Misaki
  • lung cancer Lung cancer
  • 2013